April 14, 2011 | Filed under: Health,News | Posted by:
Drugmaker Johnson & Johnson has issued a voluntary recall of 57,000 bottles of its Topamax epilepsy and migraine drug due to complaints of an “uncharacteristic odor” associated with the tablets.
Posted by
on April 14, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.